Solventum Completes Strategic Acquisition of Acera Surgical to Enhance Wound Care Solutions Solventum has successfully acquired Acera Surgical, expanding its innovative capabilities in wound care. This strategic move aligns with the company's growth objectives.

Solventum Completes Strategic Acquisition of Acera Surgical to Enhance Wound Care Solutions #United_States #Bioscience #St._Paul #Solventum #Acera_Surgical

Solventum Expands MedSurg Portfolio by Acquiring Acera Surgical for $725 Million Solventum has announced its acquisition of Acera Surgical, boosting its presence in the synthetic tissue matrices market, valued at $900 million in the U.S.

Solventum Expands MedSurg Portfolio by Acquiring Acera Surgical for $725 Million #United_States #medical_technology #St._Paul #Solventum #Acera_Surgical

Solventum Unveils Ambitious $1 Billion Share Buyback Initiative In a strategic move, Solventum announces its Board's approval for a significant $1 billion share repurchase program, aiming to enhance shareholder value through strategic capital allocation.

Solventum Unveils Ambitious $1 Billion Share Buyback Initiative #USA #share_repurchase #St._Paul #Solventum #Acera_Surgical

Acera Surgical Expands Restrata® Indications with New FDA Clearance for Soft Tissue Repair Acera Surgical has gained new FDA approval for Restrata®, enhancing its application for soft tissue reinforcement and broadening its clinical utility in surgery.

Acera Surgical Expands Restrata® Indications with New FDA Clearance for Soft Tissue Repair #United_States #FDA_Approval #St._Louis #Restrata #Acera_Surgical